InflaRx NV
F:IF0
InflaRx NV
F:IF0
Price:
1.101
EUR
4.36%
Market Cap:
€64.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Intrinsic Value
Not Available for IF0
There is not enough data to reliably calculate the intrinsic value for InflaRx NV.
Do our valuations actually work? See backtest results .
Alternatives to IF0
Fundamental Analysis
What InflaRx Does
InflaRx NV is a clinical-stage biopharmaceutical company that develops medicines for inflammatory and autoimmune diseases. Its main approach is to block a part of the immune system called complement, especially the C5a pathway, which can drive harmful inflammation in conditions where the body attacks its own tissues.
- Headquarters
- Germany DE
- Employees
- 65
- IPO date
- Nov 8, 2017
Financials
Revenue & Expenses Breakdown
InflaRx NV
InflaRx NV
Efficiency
Earnings Waterfall
InflaRx NV
InflaRx NV
